Induction and targeting of the glutamine transporter SN1 to the basolateral membranes of cortical kidney tubule cells during chronic metabolic acidosis suggest a role in pH regulation. 2005

Tom Tallak Solbu, and Jean-Luc Boulland, and Wasim Zahid, and May Kristin Lyamouri Bredahl, and Mahmood Amiry-Moghaddam, and Jon Storm-Mathisen, and Bjørg Ase Roberg, and Farrukh A Chaudhry
Department of Anatomy and Centre for Molecular Biology and Neuroscience, Institute of Basic Medical Sciences, P.O. Box 1105 Blindern, University of Oslo, N-0317 Oslo, Norway.

During chronic metabolic acidosis (CMA), the plasma levels of glutamine are increased and so is glutamine metabolism in the kidney tubule cells. Degradation of glutamine results in the formation of ammonium (NH(4)(+)) and bicarbonate (HCO(3)(-)) ions, which are excreted in the pre-urine and transported to the peritubular blood, respectively. This process contributes to counteract acidosis and to restore normal pH, but the molecular mechanism, the localization of the proteins involved and the regulation of glutamine transport into the renal tubular cells, remains unknown. SN1, a Na(+)- and H(+)-dependent glutamine transporter has previously been identified molecularly, and its mRNA has been detected in tubule cells in the medulla of the kidney. Now shown is the selective targeting of the protein to the basolateral membranes of the renal tubule cells of the S3 segment throughout development of the normal rat kidney. During CMA, SN1 expression increases five- to six-fold and appears also in cortical tubule cells in parallel with the increased expression and activity of phosphate-activated glutaminase, a mitochondrial enzyme involved in ammoniagenesis. However, SN1 remains sorted to the basolateral membranes. The unique ability of SN1 to change transport direction according to physiologic changes in transmembrane gradients of [glutamine] and pH and its sorting to the basolateral membranes and the presence of a putative pH responsive element in the 3' untranslated region (UTR) of the gene (supported here by the demonstration in CMA kidney of a protein that binds SN1 mRNA) are conducive to the function of this transporter in pH regulation.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007672 Kidney Cortex The outer zone of the KIDNEY, beneath the capsule, consisting of KIDNEY GLOMERULUS; KIDNEY TUBULES, DISTAL; and KIDNEY TUBULES, PROXIMAL. Cortex, Kidney
D007684 Kidney Tubules Long convoluted tubules in the nephrons. They collect filtrate from blood passing through the KIDNEY GLOMERULUS and process this filtrate into URINE. Each renal tubule consists of a BOWMAN CAPSULE; PROXIMAL KIDNEY TUBULE; LOOP OF HENLE; DISTAL KIDNEY TUBULE; and KIDNEY COLLECTING DUCT leading to the central cavity of the kidney (KIDNEY PELVIS) that connects to the URETER. Kidney Tubule,Tubule, Kidney,Tubules, Kidney
D009399 Nephrons The functional units of the kidney, consisting of the glomerulus and the attached tubule. Nephron
D011522 Protons Stable elementary particles having the smallest known positive charge, found in the nuclei of all elements. The proton mass is less than that of a neutron. A proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion. Hydrogen Ions,Hydrogen Ion,Ion, Hydrogen,Ions, Hydrogen,Proton
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000138 Acidosis A pathologic condition of acid accumulation or depletion of base in the body. The two main types are RESPIRATORY ACIDOSIS and metabolic acidosis, due to metabolic acid build up. Metabolic Acidosis,Acidoses,Acidoses, Metabolic,Acidosis, Metabolic,Metabolic Acidoses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

Tom Tallak Solbu, and Jean-Luc Boulland, and Wasim Zahid, and May Kristin Lyamouri Bredahl, and Mahmood Amiry-Moghaddam, and Jon Storm-Mathisen, and Bjørg Ase Roberg, and Farrukh A Chaudhry
November 2002, American journal of physiology. Renal physiology,
Tom Tallak Solbu, and Jean-Luc Boulland, and Wasim Zahid, and May Kristin Lyamouri Bredahl, and Mahmood Amiry-Moghaddam, and Jon Storm-Mathisen, and Bjørg Ase Roberg, and Farrukh A Chaudhry
January 2007, American journal of physiology. Renal physiology,
Tom Tallak Solbu, and Jean-Luc Boulland, and Wasim Zahid, and May Kristin Lyamouri Bredahl, and Mahmood Amiry-Moghaddam, and Jon Storm-Mathisen, and Bjørg Ase Roberg, and Farrukh A Chaudhry
February 2002, The Journal of physiology,
Tom Tallak Solbu, and Jean-Luc Boulland, and Wasim Zahid, and May Kristin Lyamouri Bredahl, and Mahmood Amiry-Moghaddam, and Jon Storm-Mathisen, and Bjørg Ase Roberg, and Farrukh A Chaudhry
June 1992, The American journal of physiology,
Tom Tallak Solbu, and Jean-Luc Boulland, and Wasim Zahid, and May Kristin Lyamouri Bredahl, and Mahmood Amiry-Moghaddam, and Jon Storm-Mathisen, and Bjørg Ase Roberg, and Farrukh A Chaudhry
October 2021, International journal of molecular sciences,
Tom Tallak Solbu, and Jean-Luc Boulland, and Wasim Zahid, and May Kristin Lyamouri Bredahl, and Mahmood Amiry-Moghaddam, and Jon Storm-Mathisen, and Bjørg Ase Roberg, and Farrukh A Chaudhry
April 2018, Scientific reports,
Tom Tallak Solbu, and Jean-Luc Boulland, and Wasim Zahid, and May Kristin Lyamouri Bredahl, and Mahmood Amiry-Moghaddam, and Jon Storm-Mathisen, and Bjørg Ase Roberg, and Farrukh A Chaudhry
August 1978, The Biochemical journal,
Tom Tallak Solbu, and Jean-Luc Boulland, and Wasim Zahid, and May Kristin Lyamouri Bredahl, and Mahmood Amiry-Moghaddam, and Jon Storm-Mathisen, and Bjørg Ase Roberg, and Farrukh A Chaudhry
June 1988, Metabolism: clinical and experimental,
Tom Tallak Solbu, and Jean-Luc Boulland, and Wasim Zahid, and May Kristin Lyamouri Bredahl, and Mahmood Amiry-Moghaddam, and Jon Storm-Mathisen, and Bjørg Ase Roberg, and Farrukh A Chaudhry
July 2018, Current eye research,
Tom Tallak Solbu, and Jean-Luc Boulland, and Wasim Zahid, and May Kristin Lyamouri Bredahl, and Mahmood Amiry-Moghaddam, and Jon Storm-Mathisen, and Bjørg Ase Roberg, and Farrukh A Chaudhry
June 2003, Biochemical and biophysical research communications,
Copied contents to your clipboard!